Active	Status	Sponsor type	Region	Phase	Filter
1 Active 5 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
recombinant human tissue kallikrein (DM-199) / DiaMedica
ReMEDy2, NCT05065216: Treatment of Acute Ischemic Stroke ( Trial)	Recruiting	2/3	728	US	Recombinant human tissue kallikrein, DM199	DiaMedica Therapeutics Inc	Acute Stroke, Ischemic Stroke, Stroke	12/25	03/26